Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register.
ConditionCOPD Exacerbation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorAlexis FERRE
About this trial
The objective of this prospective observational study is to describe the epidemiological, clinical and biological characteristics of admitted patients in ICU for severe acute exacerbation of COPD, to assess the different therapeutics used, to evaluate the prognosis of patients with short, medium and long term ( 1 year) and the various factors associated with survival in ICU
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 40 years old
COPD documented or strongly suspected
Chronic respiratory symptoms (dyspnoea, cough and/or sputum)
Exposure to a known risk factor for COPD (such as tobacco smoke)
Disqualifiers
Known asthma (according to the criteria of the international "Global initiative for asthma" guidelines)
Patient refusal to participate (information note, application for non-opposition)
Trial population
patients with severe acute exacerbation of COPD admitted in ICU
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
register
Other interventionMulticentre prospective observational register
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
the epidemiological, clinical and biological characteristics of patients admitted to the ICU for a severe acute exacerbation of COPD
to describe the epidemiological, clinical and biological characteristics of patients admitted to the ICU for a severe acute exacerbation of COPD
Time frame
5 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Alexis FERRE
Lead sponsor
Versailles Hospital
Sponsor institution
Source ClinicalTrials.gov